Navigation Links
Whiplash May Result in Delayed Jaw Pain
Date:8/30/2007

Trauma patients 5 times more likely to suffer facial dysfunction after a crash

THURSDAY, Aug. 30 (HealthDay News) -- About one in three people who suffer whiplash is at risk of developing delayed jaw pain/dysfunction that may require treatment, a Swedish study finds.

Publishing in the August issue of the Journal of the American Dental Association, researchers at Umea University studied short- and long-term temporomandibular joint (TMJ) pain and dysfunction in 60 patients involved in rear-end car collisions. The patients were checked when they were brought to hospital emergency rooms after a crash, and again one year later.

Patients who suffered whiplash were five times more likely to have TMJ pain and/or dysfunction immediately after a crash than uninjured people in a control group. A year later, 34 percent of whiplash patients had developed TMJ symptoms, compared with 7 percent of those in the control group.

The TM joints, located on each side of the head, work together to enable movements needed to speak and chew. Problems that affect the proper function of this system of muscles, ligaments, discs and bones can result in a painful TMJ disorder, according to the American Dental Association.

More information

The U.S. National Institute of Dental and Craniofacial Disorders has more about TMJ disorders.



-- Robert Preidt



SOURCE: American Dental Association, news release, August 2007


'/>"/>
Copyright©2007 ScoutNews,LLC.
All rights reserved

Page: 1

Related medicine news :

1. Whiplash injury causes persistent
2. The Silver Lining after a Whiplash Injury
3. Aggressive Treatment for Whiplash Does Not Promote Faster Recovery
4. Childhood Strokes Linked to Whiplash, Other Traumatic Injury
5. Experimental treatment for Ebola Virus Shows promising results in mice
6. Hormone Deficiency Results In Miscarriage
7. Patients Pressure Would Result In Overprescription
8. Traffic Violations Result in Safer Drivers
9. Heavy Computer Use May Result In Glaucoma
10. Gleevec gets hopeful results
11. Vision loss could result due to MSG
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2017)... ... 2017 , ... Crossover Symmetry , an evidence based ... lifestyle company that provides Human Performance Training and education to tactical athletes. Together ... military officers and others in service through the development and conditioning of overall ...
(Date:4/21/2017)... ... April 21, 2017 , ... Northern California Medical ... Care Spring Symposium on April 1, 2017 in Santa Rosa. This well-attended annual ... healthcare providers an opportunity to learn about cutting edge treatments, to collaborate, share ...
(Date:4/21/2017)... ... April 21, 2017 , ... BrightStar Care Salt Lake City, a ... Care of Utah (APCUT) and has appointed Rex Wheeler as its new Director of ... for our agency and our ability to provide quality care to the community,” said ...
(Date:4/21/2017)... ... , ... During April 21-23, Super-Sod will join the vendor market of the ... everyone — from the avid gardener to the landscape admirer — during the three-day ... in a grand venue, and we are certainly looking forward to participating in this ...
(Date:4/21/2017)... ... April 21, 2017 , ... National pest management association survey conducted ... of bed bug infestations over the 5-year period. In 2015 10% or US$750 million ... of bed bug infested properties. , The health and economic consequences of bed ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... , April 19, 2017  Sorrento Therapeutics, Inc. ... clinical-stage biopharmaceutical company developing new treatments for cancer ... closing of its previously announced underwritten public offering ... a public offering price of $2.00 per share, ... offering expenses payable by Sorrento.  The net proceeds ...
(Date:4/18/2017)... -- Cardinal Health (NYSE: CAH ) today is ... share (EPS) guidance and providing a preliminary view on ... this morning,s announcement of the planned acquisition of Medtronic,s ... Cardinal Health now believes that fiscal 2017 ... bottom of its previous guidance range of $5.35 to ...
(Date:4/18/2017)... BLOOMINGTON, Minn. , April 18, ... IMMY ) ("Imprimis"), an ophthalmology-focused pharmaceutical company, and ... today announced the signing of a three-year exclusive ... will deploy a dedicated sales team to introduce ... U.S., primarily focused in 13 states in the ...
Breaking Medicine Technology: